[(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate

C30H46N4O7 — CID 143651288

IUPAC[(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate
SMILESCOC1CC/C=C(\C)C(=O)NC2=CC(=O)C(NCCN(C)C)=C(CCC[C@H](OC)CC/C=C(\C)C1OC(N)=O)C2=O
InChIInChI=1S/C30H46N4O7/c1-19-10-7-12-21(39-5)13-9-14-22-26(32-16-17-34(3)4)24(35)18-23(27(22)36)33-29(37)20(2)11-8-15-25(40-6)28(19)41-30(31)38/h10-11,18,21,25,28,32H,7-9,12-17H2,1-6H3,(H2,31,38)(H,33,37)/b19-10+,20-11+/t21-,25?,28?/m1/s1
InChIKeyRUVRRBJQTKVPLA-NXUOUQFUSA-N
MW574.72 g/mol
LogP2.67
Rot. Bonds7

About [(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate

[(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate (PubChem CID 143651288) has the molecular formula C30H46N4O7 and a molecular weight of 574.72 g/mol. Its IUPAC name is [(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate.

Molecular Properties

Compound Name[(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate
PubChem CID143651288
Molecular FormulaC30H46N4O7
Molecular Weight574.72 g/mol
Exact Mass574.34
IUPAC Name[(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate
SMILESCOC1CC/C=C(\C)C(=O)NC2=CC(=O)C(NCCN(C)C)=C(CCC[C@H](OC)CC/C=C(\C)C1OC(N)=O)C2=O
InChIInChI=1S/C30H46N4O7/c1-19-10-7-12-21(39-5)13-9-14-22-26(32-16-17-34(3)4)24(35)18-23(27(22)36)33-29(37)20(2)11-8-15-25(40-6)28(19)41-30(31)38/h10-11,18,21,25,28,32H,7-9,12-17H2,1-6H3,(H2,31,38)(H,33,37)/b19-10+,20-11+/t21-,25?,28?/m1/s1
InChIKeyRUVRRBJQTKVPLA-NXUOUQFUSA-N
XLogP2.67
TPSA149.29 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms41
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500574.72
LogP ≤ 52.67
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quinone_A(370)', 'substructure': 'N/A'}, {'alert_name': 'chinone_1', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate?
The IUPAC name of [(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate (CID 143651288) is [(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate.
What is the SMILES notation for [(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate?
The canonical SMILES for [(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate is COC1CC/C=C(\C)C(=O)NC2=CC(=O)C(NCCN(C)C)=C(CCC[C@H](OC)CC/C=C(\C)C1OC(N)=O)C2=O.
What is the InChIKey of [(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate?
The InChIKey is RUVRRBJQTKVPLA-NXUOUQFUSA-N. The full InChI is InChI=1S/C30H46N4O7/c1-19-10-7-12-21(39-5)13-9-14-22-26(32-16-17-34(3)4)24(35)18-23(27(22)36)33-29(37)20(2)11-8-15-25(40-6)28(19)41-30(31)38/h10-11,18,21,25,28,32H,7-9,12-17H2,1-6H3,(H2,31,38)(H,33,37)/b19-10+,20-11+/t21-,25?,28?/m1/s1.
What are the key properties of [(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate?
[(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate has a molecular weight of 574.72 g/mol, XLogP of 2.67, 7 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [(4E,10E,14S)-19-[2-(dimethylamino)ethylamino]-8,14-dimethoxy-4,10-dimethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18-tetraen-9-yl] carbamate is sourced from PubChem (CID 143651288), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).